Medicine News and Research

RSS

Administering ondansetron drug to children is economically advantageous

Two years ago, a study by University of North Carolina at Chapel Hill researchers found that an anti-vomiting drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.Now a new economic analysis led by Canadian researchers, in collaboration with Michael J. Steiner, MD, assistant professor of pediatrics at UNC, concludes that routinely giving ondansetron to children with gastroenteritis-induced vomiting would prevent thousands of hospitalizations and save millions of dollars each year.

15 Oct 2010

Enzo Biochem fiscal 2010 total revenues increase 8% to $97.1 million

Enzo Biochem, Inc. today reported results for the fiscal fourth quarter, consistent with our announcement on September 20, 2010, and for the year ended July 31, 2010.

15 Oct 2010

FibroGen announces initiation of FG-3019 phase 2 study for reversing liver fibrosis

FibroGen, Inc. today announced initiation of a phase 2 study to compare the efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), with placebo in reversing liver fibrosis (scarring of the liver) due to chronic infection with hepatitis B virus (HBV).

15 Oct 2010

Genzyme reports five-year patient data from Phase 2 multiple sclerosis trial

Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.

15 Oct 2010

VertiFlex enrolls patients in Superion IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 200 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

15 Oct 2010

Costs for end-of-life care rising, hospice care may be an antidote

Health care costs at the end of life show no signs of leveling off, according to new research from the United States and Canada published in the Archives of Internal Medicine.

15 Oct 2010

FDG positron emission tomography allows early diagnosis of gall bladder cancer

Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.

15 Oct 2010

IOM Report: Food nutrition labels should be simple, on front

The food industry should provide simple, clearly-worded nutrition information on the front of food packages, according to a new report from the Institute of Medicine.

15 Oct 2010

PMM launches Amputation Prevention Centers of America

Paradigm Medical Management, Inc, a company dedicated to the development, implementation, and management of hospital outpatient wound care, amputation prevention and hyperbaric medicine centers, introduced Amputation Prevention Centers of America, a specialized division of PMM that addresses severe wounds and prevents unnecessary amputations.

14 Oct 2010

Bayhill to present BHT-3009 Phase 2 clinical trial data at European Committee Congress

Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company leveraging its proprietary BHT-DNA platform to develop targeted autoimmune disease treatments, today announced that it will present at the 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in MS in Gothenburg, Sweden, data from its concluded Phase 2 clinical trial showing that baseline blood plasma anti-MBP (myelin basic protein) profiles identify responders to BHT-3009 treatment.

14 Oct 2010

Childrens Hospital Los Angeles receives $1M NCI grant for eye port clinical trial to treat retinoblastoma in children

The Vision Center at Childrens Hospital Los Angeles has been awarded a $1 million grant from the National Cancer Institute (NCI) to conduct a clinical trial on a new drug delivery system to treat young children diagnosed with retinoblastoma. The device is designed to deliver chemotherapy through a tiny silicone cup sealed to the outer surface (sclera) of the eye, which can more directly target cancer cells and greatly reduce the side effects caused by current chemotherapy treatments.

14 Oct 2010

Highlighting calories, saturated fat, trans fat, and sodium in food packaging nutrition rating systems needed

Nutrition rating systems and symbols on the fronts of food packaging would be most useful to shoppers if they highlighted four nutrients of greatest concern - calories, saturated fat, trans fat, and sodium - says a new report from the Institute of Medicine. These food components are routinely overconsumed and associated most strongly with diet-related health problems affecting many Americans, including obesity, heart disease, high blood pressure, Type 2 diabetes, and certain types of cancer.

14 Oct 2010

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a scientific paper demonstrating strong and protective immune responses from candidate SynCon™ DNA vaccines in preclinical studies using Inovio's intradermal (ID) DNA delivery technology was one of the top cited scientific articles in the past three years in the journal Vaccine.

14 Oct 2010

Center for Global Health faculty to participate in consortium to enhance medical knowledge in Nigeria

Northwestern University Feinberg School of Medicine is among the U.S. medical schools and universities involved in an initiative to invest $130 million over five years to transform African medical education and dramatically increase the number of health workers.

14 Oct 2010

More minorities enroll in U.S. medical schools in 2010

More minorities enrolled in U.S. medical schools this year, according to new data released today by the AAMC (Association of American Medical Colleges). While total enrollment increased by 1.5 percent over 2009, to 18,665 students, all underrepresented racial and ethnic groups saw gains in 2010.

14 Oct 2010

Yoga exercises may combat fibromyalgia: Research

According to new research conducted at Oregon Health & Science University, yoga exercises may have the power to combat fibromyalgia a medical disorder characterized by chronic widespread pain. The research is being published in the November 10 online edition of the journal Pain and will appear online Thursday, Oct. 14.

14 Oct 2010

PPC offers on-site medication dispensing programs for hospitals

The fastest-growing privately held healthcare company in the country is building its business by building in-office medication dispensing programs for physicians and hospitals in 10 states. Incorporated just five years ago, Physicians' Pharmaceutical Corporation (PPC) placed No. 1 among health companies and No. 15 overall on the 2010 Inc. 5000 list of fastest-growing companies.

14 Oct 2010

IVF is now consider as first-line infertility treatment

With the Nobel prize for medicine awarded to Robert Edwards, the pioneer British biologist who developed in vitro fertilization (IVF) for humans, "any remaining doubts about the importance of 'test tube babies' that have lingered over the past 32 years ago should finally be put to rest," says Michael S. Opsahl, M.D., recently named one of "Washington State's Best Doctors" in Washington Magazine.

14 Oct 2010

Study confirms long term survival benefit of ELAD bioartificial liver support system in Chinese ACLF patients

Vital Therapies, Inc., today announced that a poster is being presented at the American Association for the Study of Liver Diseases (AASLD) meeting in Boston on Tuesday, November 2nd. It confirms that previously reported findings of improved transplant free survival (TFS) in Chinese subjects with acute-on-chronic liver failure (ACLF) treated with the ELAD® bioartificial liver support system are maintained for up to three years.

14 Oct 2010

Web-based questionnaire option increases survey response: Report

Investigators from the Slone Epidemiology Center at Boston University School of Medicine (BUSM) have reported that the use of a web-based questionnaire can be a cost-effective tool for obtaining survey response.

14 Oct 2010